Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia

被引：46

作者：

Leoni, Veronica ^{[1
]}

Biondi, Andrea

机构：

[1] Milano Bicocca Univ, Paediat Haematol Oncol Dept, San Gerardo Hosp, Fdn MBBM, Monza, Italy

来源：

HAEMATOLOGICA | 2015年 / 100卷 / 03期

关键词：

STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; ADULT PATIENTS; HYPER-CVAD; ALLOGENEIC TRANSPLANTATION; MARROW TRANSPLANTATION; COMPLETE REMISSION; REDUCED-INTENSITY; ELDERLY-PATIENTS; IMATINIB;

D O I：

10.3324/haematol.2015.124016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：295 / 299

页数：6

共 50 条

[41] BCR-ABL ONCOGENE ACTIVATION IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
HERMANS, A
GOW, J
SELLERI, L
VONLINDERN, M
HAGEMEIJER, A
WIEDEMANN, LM
GROSVELD, G
LEUKEMIA, 1988, 2 (10) : 628 - 633
[42] COMPARATIVE ANALYSIS OF POSITIVE AND NEGATIVE ACUTE LYMPHOBLASTIC LEUKAEMIA BCR-ABL1 IN THE ERA OF INHIBITORS OF TYROSINE KINASE
De Una Soraya, Lorente
Velasco Antonio, Jimenez
Maria Jose, Moreno
Manuel, Barrios
Joaquin, Ruiz
Ana Isabel, Heiniger
HAEMATOLOGICA, 2016, 101 : 160 - 160
[43] BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia
Rizzotto, Lara
Saccenti, Elena
Sofritti, Olga
Daghia, Giulia
Volta, Eleonora
Caprini, Elisabetta
Lupini, Laura
Tammiso, Elisa
Bardi, Antonella
Lista, Enrico
Ciccone, Maria
Russo, Giandomenico
Negrini, Massimo
Cuneo, Antonio
Rigolin, Gian Matteo
LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2065 - 2067
[44] Selective killing of BCR-ABL positive cells with a specific inhibitor of the ABL tyrosine kinase
Druker, BJ
Ohno, S
Buchdunger, E
Tamura, S
Zimmermann, J
Lydon, NB
CANCER GENES: FUNCTIONAL ASPECTS, 1996, 7 : 255 - 267
[45] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, BJ
Tamura, S
Buchdunger, E
Ohno, S
Segal, GM
Fanning, S
Zimmermann, J
Lydon, NB
NATURE MEDICINE, 1996, 2 (05) : 561 - 566
[46] Detection of BCR-ABL transcripts in acute lymphoblastic leukemia in Indian patients
Gurbuxani, S
Lacorte, JM
Raina, V
Arya, LS
Pepin, D
Sazawal, S
Marie, JP
Bhargava, M
LEUKEMIA RESEARCH, 1998, 22 (01) : 77 - 80
[47] Use of Tyrosine Kinase Inhibitors Post-Allogeneic Stem Cell Transplant in Patients with Philadelphia or BCR-ABL Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
Liew, Elena
Ghosh, Sunita
Saini, Lalit
BLOOD, 2016, 128 (22)
[48] Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia
刘莹
ChinaMedicalAbstracts(InternalMedicine), 2019, 36 (04) : 230 - 230
[49] Role of Vitamins A and D in BCR-ABL Arf−/− Acute Lymphoblastic Leukemia
Kavya Annu
Cynthia Cline
Kazuto Yasuda
Samit Ganguly
Andrea Pesch
Brittany Cooper
Laura Janke
Monique Payton
Kamalika Mukherjee
Sherri L. Surman
Julia L. Hurwitz
Erin G. Schuetz
Scientific Reports, 10
[50] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
Druker, BJ
Sawyers, CL
Kantarjian, H
Resta, DJ
Reese, SF
Ford, JM
Capdeville, R
Talpaz, M
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1038 - 1042

← 1 2 3 4 5 →